Treatment regimen for Hodgkins lymphoma is: September 2008
**Core Concept**
The treatment regimen for Hodgkin's lymphoma involves a combination of chemotherapy and radiation therapy to target and eliminate cancerous cells. The specific regimen is tailored to the stage and extent of the disease, as well as the patient's overall health and tolerance to treatment.
**Why the Correct Answer is Right**
The ABVD regimen, which consists of Adriamycin (doxorubicin), Bleomycin, Vinblastine, and Dacarbazine, has become the standard of care for Hodgkin's lymphoma due to its efficacy and relatively favorable toxicity profile. This regimen works by targeting rapidly dividing cancer cells with chemotherapy agents that interfere with DNA replication and cell division. The combination of these agents has been shown to be highly effective in inducing remission and improving survival rates in patients with Hodgkin's lymphoma.
**Why Each Wrong Option is Incorrect**
* **Option A:** ABVC - This option is incorrect because it lacks the essential component of Dacarbazine, which is a critical component of the ABVD regimen.
* **Option B:** ABWE - This option is incorrect because it replaces Dacarbazine with an ineffective agent, and the efficacy of the regimen is compromised.
* **Option C:** ABVE - This option is incorrect because it replaces Vinblastine with an ineffective agent, which can lead to reduced efficacy and increased toxicity.
**Clinical Pearl / High-Yield Fact**
The ABVD regimen has been shown to be highly effective in Hodgkin's lymphoma, with a reported complete remission rate of up to 90% in some studies. It is essential to note that the specific regimen and treatment duration may vary depending on the stage and extent of the disease.
**Correct Answer:** A. ABVD